Lazard Asset Management’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-916,978
| Closed | -$1.86M | – | 1152 |
|
|
2016
Q1 | $1.86M | Buy |
916,978
+762,193
| +492% | +$1.36M | ﹤0.01% | 613 |
|
|
2015
Q4 | $383K | Sell |
154,785
-64,176
| -29% | -$190K | ﹤0.01% | 745 |
|
|
2015
Q3 | $569K | Sell |
218,961
-1,082,577
| -83% | -$2.82M | ﹤0.01% | 694 |
|
|
2015
Q2 | $4.09M | Buy |
1,301,538
+35,621
| +3% | +$122K | 0.01% | 555 |
|
|
2015
Q1 | $3.62M | Sell |
1,265,917
-239,917
| -16% | -$613K | 0.01% | 575 |
|
|
2014
Q4 | $3.88M | Buy |
1,505,834
+241,500
| +19% | +$1.06M | 0.01% | 576 |
|
|
2014
Q3 | $9.43M | Sell |
1,264,334
-6,983
| -0.5% | -$65.2K | 0.02% | 396 |
|
|
2014
Q2 | $15M | Buy |
1,271,317
+881,365
| +226% | +$9.4M | 0.03% | 319 |
|
|
2014
Q1 | $4.53M | Sell |
389,952
-472,582
| -55% | -$5.56M | 0.01% | 496 |
|
|
2013
Q4 | $9.39M | Buy |
862,534
+106,988
| +14% | +$1.05M | 0.02% | 382 |
|
|
2013
Q3 | $8.14M | Buy |
755,546
+161,477
| +27% | +$1.84M | 0.02% | 400 |
|
|
2013
Q2 | $6.96M | Buy |
+594,069
| New | +$5.93M | 0.02% | 443 |
|
Lazard Asset Management's SZYM Position: Q2 2016 in Review
Lazard Asset Management sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 916,978 shares — an estimated $1.86M sold.
Lazard Asset Management first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $15M in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.
- Lazard Asset Management reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
- Lazard Asset Management sold 916,978 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $1.86M.
- Lazard Asset Management first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
- Lazard Asset Management's SOLAZYME INC COM STK (DE) position peaked at $15M in Q2 2014.
- 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.
Based on Lazard Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.